These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3550674)

  • 21. Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats.
    Sami IR; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA
    J Infect Dis; 1995 Feb; 171(2):440-3. PubMed ID: 7844385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of cytotoxic activity in lungs to recovery of normal and gamma-irradiated cotton rats from respiratory syncytial virus infection.
    Sun CS; Wyde PR; Knight V
    Am Rev Respir Dis; 1983 Oct; 128(4):668-72. PubMed ID: 6354026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribavirin: ready for RSV season.
    Lerner-DurJava L
    Neonatal Netw; 1988 Dec; 7(3):49-51. PubMed ID: 3205241
    [No Abstract]   [Full Text] [Related]  

  • 24. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
    Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribavirin: ready for RSV season.
    Piontek-Lentz TC
    Neonatal Netw; 1988 Oct; 7(2):29-35. PubMed ID: 3173320
    [No Abstract]   [Full Text] [Related]  

  • 26. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.
    Hynicka LM; Ensor CR
    Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic.
    Conrad DA; Christenson JC; Waner JL; Marks MI
    Pediatr Infect Dis J; 1987 Feb; 6(2):152-8. PubMed ID: 3562136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
    Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
    Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribavirin (virazole): a novel antiviral agent against viral respiratory tract infections.
    Ahmed ME; Branch RA
    Ration Drug Ther; 1986 Nov; 20(11):1-3. PubMed ID: 3588934
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of ribavirin aerosol treatment for respiratory syncytial virus bronchiolitis in infants.
    Caramia G; Palazzini E
    J Int Med Res; 1987; 15(4):227-33. PubMed ID: 3653500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus.
    Fisher RG; Crowe JE; Johnson TR; Tang YW; Graham BS
    J Infect Dis; 1999 Oct; 180(4):1324-7. PubMed ID: 10479165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical review of ribavirin.
    Eggleston M
    Infect Control; 1987 May; 8(5):215-8. PubMed ID: 3298116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated cytotoxic responses in lungs of cotton rats infected with respiratory syncytial virus.
    Sun CS; Wyde PR; Wilson SZ; Knight V
    Am Rev Respir Dis; 1983 Apr; 127(4):460-4. PubMed ID: 6340570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats.
    Wyde PR; Ambrose MW; Meyer HL; Zolinski CL; Gilbert BE
    Antiviral Res; 1990; 14(4-5):215-25. PubMed ID: 1965109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.
    Prince GA; Horswood RL; Chanock RM
    J Virol; 1985 Sep; 55(3):517-20. PubMed ID: 4020957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis.
    Hemming VG; Prince GA
    Rev Infect Dis; 1990; 12 Suppl 4():S470-4; discussion S474-5. PubMed ID: 2194271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the anti-respiratory syncytial virus activity and toxicity of papaverine hydrochloride and pyrazofurin in vitro and in vivo.
    Wyde PR; Gilbert BE; Ambrose MW
    Antiviral Res; 1989 Feb; 11(1):15-26. PubMed ID: 2653219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection.
    Rosner IK; Welliver RC; Edelson PJ; Geraci-Ciardullo K; Sun M
    J Infect Dis; 1987 May; 155(5):1043-7. PubMed ID: 3559277
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies.
    Walsh EE; Schlesinger JJ; Brandriss MW
    Infect Immun; 1984 Feb; 43(2):756-8. PubMed ID: 6363300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe respiratory syncytial virus pneumonia in an adult renal transplant recipient: successful treatment with ribavirin.
    Peigue-Lafeuille H; Gazuy N; Mignot P; Deteix P; Beytout D; Baguet JC
    Scand J Infect Dis; 1990; 22(1):87-9. PubMed ID: 2320966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.